EPTMF (Epitomee Medical) Research & Development: $5.40 Mil (TTM As of Dec. 2025)


EPTMF Epitomee Medical Ltd EPTMF
29 GF Score
Price $0.99
! 3 Warning Signs
View Full Analysis

What is Epitomee Medical Research & Development?

Epitomee Medical EPTMF 29 Research & Development is $5.40 Mil as of Dec. 2025. GuruFocus rates EPTMF with a GF Score™ of 29/100. The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Epitomee Medical's Research & Development for the six months ended in Dec. 2025 was $2.36 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was $5.40 Mil.

Epitomee Medical  (OTCPK:EPTMF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Epitomee Medical Research & Development Related Terms

Epitomee Medical Research & Development Historical Data

* Premium members only.

The historical data trend for Epitomee Medical's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Epitomee Medical Research & Development Chart

Epitomee Medical Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 6.18 7.79 6.80 5.54 5.40

Epitomee Medical Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.04 2.83 2.70 3.05 2.36
EPTMF
29GF Score
Epitomee Medical Ltd EPTMF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Epitomee Medical Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $5.40 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $5.40 Mil mean?
Epitomee Medical (EPTMF) has a Research & Development of $5.40 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Epitomee Medical and its competitors.
Is Epitomee Medical's Research & Development too high?
Epitomee Medical's current Research & Development is $5.40 Mil. Overall, Epitomee Medical has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Epitomee Medical's Research & Development compare to ABT and SYK?
Epitomee Medical's Research & Development of $5.40 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Epitomee Medical and its competitors. Epitomee Medical's current Research & Development is $5.40 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Epitomee Medical stock overvalued right now?
Epitomee Medical (EPTMF) has a current Research & Development of $5.40 Mil. The current Research & Development is $5.40 Mil. Epitomee Medical's overall GF Score™ is 29/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Epitomee Medical (EPTMF), the current Research & Development is $5.40 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Epitomee Medical Business Description

Other Exchanges EPIT:Israel
Address Tarshish 19, Caesarea, ISR, 3088900
Epitomee Medical Ltd is engaged in developing and commercializing ingestible therapeutic devices.
29GF Score

Get the complete analysis for EPTMF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.99
Price